Correlation Between C4 Therapeutics and Graphite Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Graphite Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Graphite Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Graphite Bio, you can compare the effects of market volatilities on C4 Therapeutics and Graphite Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Graphite Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Graphite Bio.

Diversification Opportunities for C4 Therapeutics and Graphite Bio

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between CCCC and Graphite is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Graphite Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Graphite Bio and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Graphite Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Graphite Bio has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Graphite Bio go up and down completely randomly.

Pair Corralation between C4 Therapeutics and Graphite Bio

Given the investment horizon of 90 days C4 Therapeutics is expected to generate 4.27 times more return on investment than Graphite Bio. However, C4 Therapeutics is 4.27 times more volatile than Graphite Bio. It trades about 0.04 of its potential returns per unit of risk. Graphite Bio is currently generating about -0.07 per unit of risk. If you would invest  348.00  in C4 Therapeutics on September 1, 2024 and sell it today you would earn a total of  107.00  from holding C4 Therapeutics or generate 30.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy8.33%
ValuesDaily Returns

C4 Therapeutics  vs.  Graphite Bio

 Performance 
       Timeline  
C4 Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days C4 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Graphite Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Graphite Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Graphite Bio is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

C4 Therapeutics and Graphite Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with C4 Therapeutics and Graphite Bio

The main advantage of trading using opposite C4 Therapeutics and Graphite Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Graphite Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Graphite Bio will offset losses from the drop in Graphite Bio's long position.
The idea behind C4 Therapeutics and Graphite Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital